Why Didn’t You Text Me? Poststudy Trends From the DepoText Trial

Objective. To evaluate the longitudinal impact of a 9-month text message intervention on participant adherence beyond the intervention to highly effective contraceptive methods among urban adolescent and young adult women enrolled in the DepoText randomized control trial (RCT). Study Design. Retrosp...

Full description

Saved in:
Bibliographic Details
Published in:Clinical pediatrics 2018-01, Vol.57 (1), p.82-88
Main Authors: Buchanan, Cara R. Muñoz, Tomaszewski, Kathy, Chung, Shang-en, Upadhya, Krishna K., Ramsey, Alexandra, Trent, Maria E.
Format: Article
Language:English
Subjects:
Acetic acid
Adolescent
Adult
Baltimore
Choice Behavior
Cohort Studies
Contraceptive Agents, Female - therapeutic use
Female
Humans
Longitudinal Studies
Medroxyprogesterone acetate
Medroxyprogesterone Acetate - therapeutic use
Patient Compliance - statistics & numerical data
Pilot Projects
Program Evaluation - methods
Reminder Systems
Retrospective Studies
Teenagers
Text Messaging - statistics & numerical data
Urban Population - statistics & numerical data
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective. To evaluate the longitudinal impact of a 9-month text message intervention on participant adherence beyond the intervention to highly effective contraceptive methods among urban adolescent and young adult women enrolled in the DepoText randomized control trial (RCT). Study Design. Retrospective longitudinal cohort study of long-term follow-up data from the DepoText RCT. Sixty-seven female participants (aged 13-21 years) using depot medroxyprogesterone acetate (DMPA) were recruited from an urban academic adolescent practice in Baltimore, Maryland. The principal outcome measured was a comparison of contraceptive method choice between the control and intervention groups during the 20 months postintervention. Results. Intervention participants were 3.65 times more likely to continue using DMPA or a more efficacious method at the 20-month postintervention evaluation (odds ratio 3.65, 95% CI 1.26-10.08; P = .015). Conclusion. Participation in the DepoText trial was associated with continued use of DMPA or a more effective contraceptive method almost 20 months after the intervention exposure ended.
ISSN:0009-9228
1938-2707
DOI:10.1177/0009922816689674